The Georgia General Assembly has passed a bill aimed at ensuring Medicaid covers the latest treatments for sickle cell anemia, sending it to Governor Brian Kemp's desk after advocates gathered at the state Capitol to push for its passage.
Sickle cell disease disproportionately affects Black Americans, and Georgia has one of the highest rates of the condition in the country. The bill would require the state's Medicaid program to cover currently available treatments, including newer therapies that have shown promise in reducing the painful episodes and hospitalizations that define the disease.
Advocates who traveled to the Capitol to testify in favor of the bill shared personal stories of living with sickle cell or caring for family members with the condition. Their testimony helped frame the legislation not as an abstract policy question but as a matter of basic healthcare access for thousands of Georgians.
The bill's passage came during the final stretch of the 2026 legislative session, which wrapped up last week. If signed by the governor, it would represent one of the session's most significant healthcare wins, expanding coverage for a patient population that has historically faced barriers to accessing the care they need.
Atlanta's medical community, including providers at Grady Memorial Hospital and Emory Healthcare who treat a significant number of sickle cell patients, has been vocal in supporting expanded coverage.
